Authors: Wiesner, GL Platzer, P Buxbaum, S Lewis, S MacMillen, M Olechnowicz, J Willis, J Chakravarti, A Elston, RC Markowitz, SD

Citation: Gl. Wiesner et al., Testing for colon neoplasia susceptibility variants at the human COX2 locus, J NAT CANC, 93(8), 2001, pp. 635-639

Authors: Wiesner, GL Platzer, P Buxbaum, SG Lewis, S MacMillen, M Willis, J Chakravarti, A Elston, RC Markowitz, SD

Citation: Gl. Wiesner et al., Testing for colon neoplasia susceptibility variants at the human COX2 locus - Response, J NAT CANC, 93(20), 2001, pp. 1573-1574

Authors: Platzer, P Thalhammer, T Reznicek, G Hamilton, G Zhang, RW Jager, W

Citation: P. Platzer et al., Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver, INT J ONCOL, 19(6), 2001, pp. 1287-1293

Authors: Platzer, P Thalhammer, T Hamilton, G Ulsperger, E Rosenberg, E Wissiack, R Jager, W

Citation: P. Platzer et al., Metabolism of camptothecin, a potent topoisomerase I inhibitor, in the isolated perfused rat liver, CANC CHEMOT, 45(1), 2000, pp. 50-54

Authors: Jager, W Mayer, M Platzer, P Reznicek, G Dietrich, H Buchbauer, G

Citation: W. Jager et al., Stereoselective metabolism of the monoterpene carvone by rat and human liver microsomes, J PHARM PHA, 52(2), 2000, pp. 191-197

Authors: Ertl, B Platzer, P Wirth, M Gabor, F

Citation: B. Ertl et al., Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin, J CONTR REL, 61(3), 1999, pp. 305-317